These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Mutations in the mitofusin 2 gene are the most common cause of Charcot-Marie-Tooth type 2 disease]. Sołtysińska E; Kabzińska D; Kochański A Neurol Neurochir Pol; 2007; 41(4):350-4. PubMed ID: 17874344 [TBL] [Abstract][Full Text] [Related]
3. A cohort study of MFN2 mutations and phenotypic spectrums in Charcot-Marie-Tooth disease 2A patients. Choi BO; Nakhro K; Park HJ; Hyun YS; Lee JH; Kanwal S; Jung SC; Chung KW Clin Genet; 2015 Jun; 87(6):594-8. PubMed ID: 24863639 [TBL] [Abstract][Full Text] [Related]
4. Late-onset hereditary sensory and autonomic neuropathy expands the phenotypic spectrum of MFN2-related diseases. Wu R; Fu J; Meng L; Lv H; Wang Z; Yuan Y Neuropathology; 2018 Oct; 38(5):463-467. PubMed ID: 30011089 [TBL] [Abstract][Full Text] [Related]
5. Genotype-phenotype correlations in Charcot-Marie-Tooth disease type 2 caused by mitofusin 2 mutations. Calvo J; Funalot B; Ouvrier RA; Lazaro L; Toutain A; De Mas P; Bouche P; Gilbert-Dussardier B; Arne-Bes MC; Carrière JP; Journel H; Minot-Myhie MC; Guillou C; Ghorab K; Magy L; Sturtz F; Vallat JM; Magdelaine C Arch Neurol; 2009 Dec; 66(12):1511-6. PubMed ID: 20008656 [TBL] [Abstract][Full Text] [Related]
6. A late-onset and mild form of Charcot-Marie-Tooth disease type 2 caused by a novel splice-site mutation within the Mitofusin-2 gene. Kotruchow K; Kabzińska D; Hausmanowa-Petrusewicz I; Kochański A Acta Myol; 2013 Dec; 32(3):166-9. PubMed ID: 24803844 [TBL] [Abstract][Full Text] [Related]
7. Early onset severe and late-onset mild Charcot-Marie-Tooth disease with mitofusin 2 (MFN2) mutations. Chung KW; Kim SB; Park KD; Choi KG; Lee JH; Eun HW; Suh JS; Hwang JH; Kim WK; Seo BC; Kim SH; Son IH; Kim SM; Sunwoo IN; Choi BO Brain; 2006 Aug; 129(Pt 8):2103-18. PubMed ID: 16835246 [TBL] [Abstract][Full Text] [Related]
8. A cohort study of Han Chinese MFN2-related Charcot-Marie-Tooth 2A. Lv H; Wang L; Zhang W; Wang Z; Zuo Y; Liu J; Yuan Y J Neurol Sci; 2015 Nov; 358(1-2):153-7. PubMed ID: 26382835 [TBL] [Abstract][Full Text] [Related]
9. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A. Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531 [TBL] [Abstract][Full Text] [Related]
10. Autosomal recessive MFN2-related Charcot-Marie-Tooth disease with diaphragmatic weakness: Case report and literature review. Tan CA; Rabideau M; Blevins A; Westbrook MJ; Ekstein T; Nykamp K; Deucher A; Harper A; Demmer L Am J Med Genet A; 2016 Jun; 170(6):1580-4. PubMed ID: 26955893 [TBL] [Abstract][Full Text] [Related]
11. A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations. Vital A; Latour P; Sole G; Ferrer X; Rouanet M; Tison F; Vital C; Goizet C Neuromuscul Disord; 2012 Aug; 22(8):735-41. PubMed ID: 22546700 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model. Strickland AV; Rebelo AP; Zhang F; Price J; Bolon B; Silva JP; Wen R; Züchner S J Peripher Nerv Syst; 2014 Jun; 19(2):152-64. PubMed ID: 24862862 [TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic diversities of Charcot-Marie-Tooth disease with MFN2 mutations in a large case study. Ando M; Hashiguchi A; Okamoto Y; Yoshimura A; Hiramatsu Y; Yuan J; Higuchi Y; Mitsui J; Ishiura H; Umemura A; Maruyama K; Matsushige T; Morishita S; Nakagawa M; Tsuji S; Takashima H J Peripher Nerv Syst; 2017 Sep; 22(3):191-199. PubMed ID: 28660751 [TBL] [Abstract][Full Text] [Related]
14. A novel p.Val244Leu mutation in MFN2 leads to Charcot-Marie-Tooth disease type 2. Yang Y; Li L Ital J Pediatr; 2016 Mar; 42():28. PubMed ID: 26956144 [TBL] [Abstract][Full Text] [Related]
15. A novel homozygous MFN2 mutation associated with severe and atypical CMT2 phenotype. Iapadre G; Morana G; Vari MS; Pinto F; Lanteri P; Tessa A; Santorelli FM; Striano P; Verrotti A Eur J Paediatr Neurol; 2018 May; 22(3):563-567. PubMed ID: 29361379 [TBL] [Abstract][Full Text] [Related]
16. MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. Verhoeven K; Claeys KG; Züchner S; Schröder JM; Weis J; Ceuterick C; Jordanova A; Nelis E; De Vriendt E; Van Hul M; Seeman P; Mazanec R; Saifi GM; Szigeti K; Mancias P; Butler IJ; Kochanski A; Ryniewicz B; De Bleecker J; Van den Bergh P; Verellen C; Van Coster R; Goemans N; Auer-Grumbach M; Robberecht W; Milic Rasic V; Nevo Y; Tournev I; Guergueltcheva V; Roelens F; Vieregge P; Vinci P; Moreno MT; Christen HJ; Shy ME; Lupski JR; Vance JM; De Jonghe P; Timmerman V Brain; 2006 Aug; 129(Pt 8):2093-102. PubMed ID: 16714318 [TBL] [Abstract][Full Text] [Related]
17. Spectrum and frequencies of mutations in the MFN2 gene and its phenotypical expression in Czech hereditary motor and sensory neuropathy type II patients. Brožková DŠ; Posádka J; Laššuthová P; Mazanec R; Haberlová J; Sišková D; Sakmaryová I; Neupauerová J; Seeman P Mol Med Rep; 2013 Dec; 8(6):1779-84. PubMed ID: 24126688 [TBL] [Abstract][Full Text] [Related]
18. Role of mitofusin 2 mutations in the physiopathology of Charcot-Marie-Tooth disease type 2A. Cartoni R; Martinou JC Exp Neurol; 2009 Aug; 218(2):268-73. PubMed ID: 19427854 [TBL] [Abstract][Full Text] [Related]
19. Charcot-Marie-Tooth disease type 2A: from typical to rare phenotypic and genotypic features. Bombelli F; Stojkovic T; Dubourg O; Echaniz-Laguna A; Tardieu S; Larcher K; Amati-Bonneau P; Latour P; Vignal O; Cazeneuve C; Brice A; Leguern E JAMA Neurol; 2014 Aug; 71(8):1036-42. PubMed ID: 24957169 [TBL] [Abstract][Full Text] [Related]
20. Novel MFN2 Missense Mutation Induces Hereditary Axonal Motor and Sensory Neuropathy in a Saudi Arabian Family. Al-Harbi TM; Abdulmana SO; Bashir S; Dridi W J Clin Neuromuscul Dis; 2019 Sep; 21(1):25-29. PubMed ID: 31453851 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]